{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:32:16Z","timestamp":1777926736027,"version":"3.51.4"},"reference-count":114,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejso.2025.110487","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T07:40:07Z","timestamp":1758699607000},"page":"110487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Crossing the blood-brain barrier: The therapeutic potential of lncRNAs in neurosurgery"],"prefix":"10.1016","volume":"51","author":[{"given":"Saba","family":"Khazeni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Yaser","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2025.110487_bib1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev-cellbio-100617-062608","article-title":"Development and cell biology of the blood-brain barrier","volume":"35","author":"Langen","year":"2019","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"9","key":"10.1016\/j.ejso.2025.110487_bib2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nri3265","article-title":"The anatomical and cellular basis of immune surveillance in the central nervous system","volume":"12","author":"Ransohoff","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.ejso.2025.110487_bib3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.tins.2020.12.002","article-title":"Blood\u2013brain barrier dynamics to maintain brain homeostasis","volume":"44","author":"Segarra","year":"2021","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.ejso.2025.110487_bib4","series-title":"The triad of blood brain barrier integrity: endothelial cells, astrocytes, and pericytes in perinatal stroke pathophysiology","author":"Mart\u00ednez","year":"2025"},{"issue":"1","key":"10.1016\/j.ejso.2025.110487_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2015.1138017","article-title":"Tight junction modulation of the blood brain barrier: CNS delivery of small molecules","volume":"4","author":"Greene","year":"2016","journal-title":"Tissue Barriers"},{"issue":"3","key":"10.1016\/j.ejso.2025.110487_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrn2995","article-title":"Engaging neuroscience to advance translational research in brain barrier biology","volume":"12","author":"Neuwelt","year":"2011","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"10.1016\/j.ejso.2025.110487_bib7","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1152\/physrev.00014.2004","article-title":"Expression and function of laminins in the embryonic and mature vasculature","volume":"85","author":"Hallmann","year":"2005","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.ejso.2025.110487_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70015","article-title":"Prenatal alcohol consumption alters protein fingerprint in umbilical cord blood serum and induces brain microvascular endothelial cell dysfunction","volume":"169","author":"Almeida","year":"2025","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.ejso.2025.110487_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tibs.2018.09.012","article-title":"Revealing lncRNA structures and interactions by sequencing-based approaches","volume":"44","author":"Qian","year":"2019","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"10.1016\/j.ejso.2025.110487_bib10","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s12094-024-03619-w","article-title":"Unveiling the functions of five recently characterized lncRNAs in cancer progression","volume":"27","author":"Li","year":"2025","journal-title":"Clin Transl Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2025.110487_bib11","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1101\/gr.132159.111","article-title":"The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression","volume":"22","author":"Derrien","year":"2012","journal-title":"Genome Res"},{"issue":"7414","key":"10.1016\/j.ejso.2025.110487_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"Consortium","year":"2012","journal-title":"Nature"},{"issue":"7414","key":"10.1016\/j.ejso.2025.110487_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature11233","article-title":"Landscape of transcription in human cells","volume":"489","author":"Djebali","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejso.2025.110487_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4155\/ppa.13.4","article-title":"Oligonucleotides for upregulating gene expression","volume":"2","author":"Khorkova","year":"2013","journal-title":"Pharmac Patent Anal"},{"issue":"1","key":"10.1016\/j.ejso.2025.110487_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood\u2013brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol Dis"},{"issue":"9","key":"10.1016\/j.ejso.2025.110487_bib16","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.261776","article-title":"A short guide to the tight junction","volume":"137","author":"Citi","year":"2024","journal-title":"J Cell Sci"},{"issue":"6","key":"10.1016\/j.ejso.2025.110487_bib17","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3390\/cells10061400","article-title":"Role of intermediate filaments in blood\u2013brain barrier in health and disease","volume":"10","author":"Bayir","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.ejso.2025.110487_bib18","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.3390\/ijms25115601","article-title":"The basic requirement of tight junction proteins in blood-brain barrier function and their role in pathologies","volume":"25","author":"Dithmer","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.ejso.2025.110487_bib19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.addr.2005.01.009","article-title":"Occludin: structure, function and regulation","volume":"57","author":"Feldman","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ejso.2025.110487_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6107(02)00037-8","article-title":"Tight junction proteins","volume":"81","author":"Betanzos","year":"2003","journal-title":"Prog Biophys Mol Biol"},{"issue":"23","key":"10.1016\/j.ejso.2025.110487_bib21","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.3390\/cells12232701","article-title":"Cell adhesion at the tight junctions: new aspects and new functions","volume":"12","author":"Wibbe","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ejso.2025.110487_bib22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev-neuro-060909-152829","article-title":"Connecting vascular and nervous system development: angiogenesis and the blood-brain barrier","volume":"33","author":"Tam","year":"2010","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.ejso.2025.110487_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10571-006-9028-x","article-title":"Adrenomedullin improves the blood\u2013brain barrier function through the expression of claudin-5","volume":"26","author":"Honda","year":"2006","journal-title":"Cell Mol Neurobiol"},{"issue":"20","key":"10.1016\/j.ejso.2025.110487_bib24","doi-asserted-by":"crossref","first-page":"e2488","DOI":"10.1212\/WNL.0000000000011930","article-title":"Effect of adrenomedullin on migraine-like attacks in patients with migraine: a randomized crossover study","volume":"96","author":"Ghanizada","year":"2021","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ejso.2025.110487_bib25","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.addr.2005.01.005","article-title":"The JAM family of proteins","volume":"57","author":"Mandell","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.ejso.2025.110487_bib26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2006.08.005","article-title":"ZOning out tight junctions","volume":"126","author":"Shin","year":"2006","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ejso.2025.110487_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/pr.57.2.4","article-title":"The blood-brain barrier\/neurovascular unit in health and disease","volume":"57","author":"Hawkins","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ejso.2025.110487_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00891-07","article-title":"Early embryonic lethality of mice lacking ZO-2, but Not ZO-3, reveals critical and nonredundant roles for individual zonula occludens proteins in mammalian development","author":"Xu","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"11","key":"10.1016\/j.ejso.2025.110487_bib29","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1046\/j.1365-2443.2003.00681.x","article-title":"Expression and distribution of ZO\u20103, a tight junction MAGUK protein, in mouse tissues","volume":"8","author":"Inoko","year":"2003","journal-title":"Genes Cells"},{"issue":"3","key":"10.1016\/j.ejso.2025.110487_bib30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3233\/JAD-2010-100462","article-title":"Apical-to-basolateral transport of amyloid-\u03b2 peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein","volume":"22","author":"Candela","year":"2010","journal-title":"J Alzheim Dis"},{"issue":"5","key":"10.1016\/j.ejso.2025.110487_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3109\/02652048.2012.658445","article-title":"Delivery of drugs to the brain via the blood brain barrier using colloidal carriers","volume":"29","author":"Tucker","year":"2012","journal-title":"J Microencapsul"},{"issue":"6","key":"10.1016\/j.ejso.2025.110487_bib32","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1471-4159.2008.05720.x","article-title":"ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood\u2013brain barrier","volume":"107","author":"Dauchy","year":"2008","journal-title":"J Neurochem"},{"issue":"12","key":"10.1016\/j.ejso.2025.110487_bib33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.it.2012.07.004","article-title":"Capture, crawl, cross: the T cell code to breach the blood\u2013brain barriers","volume":"33","author":"Engelhardt","year":"2012","journal-title":"Trends Immunol"},{"issue":"5","key":"10.1016\/j.ejso.2025.110487_bib120","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70422","article-title":"Blood\u2013brain barrier (BBB) dysfunction in CNS diseases: paying attention to pericytes","volume":"31","author":"Yu","year":"2025","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"10.1016\/j.ejso.2025.110487_bib121","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte\u2013endothelial interactions at the blood\u2013brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"10.1016\/j.ejso.2025.110487_bib122","doi-asserted-by":"crossref","first-page":"R207","DOI":"10.1016\/j.cub.2017.02.006","article-title":"Basement membranes","volume":"27","author":"Jayadev","year":"2017","journal-title":"Curr Biol"},{"key":"10.1016\/j.ejso.2025.110487_bib40","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","article-title":"CNS delivery via adsorptive transcytosis","volume":"10","author":"Herv\u00e9","year":"2008","journal-title":"AAPS J"},{"issue":"2\u20133","key":"10.1016\/j.ejso.2025.110487_bib123","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(98)00083-0","article-title":"In vitro model for evaluating drug transport across the blood\u2013brain barrier","volume":"36","author":"Cecchelli","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.ejso.2025.110487_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood\u2013brain barrier: an overview: structure, regulation, and clinical implications","volume":"16","author":"Ballabh","year":"2004","journal-title":"Neurobiol Dis"},{"issue":"43","key":"10.1016\/j.ejso.2025.110487_bib125","doi-asserted-by":"crossref","first-page":"44785","DOI":"10.1074\/jbc.M406563200","article-title":"Establishment and characterization of cultured epithelial cells lacking expression of ZO-1","volume":"279","author":"Umeda","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejso.2025.110487_bib34","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jconrel.2024.11.069","article-title":"Delivery of small interfering RNA by hydrogen sulfide-releasing nanomotor for the treatment of Parkinson's disease","volume":"377","author":"Wang","year":"2025","journal-title":"J Contr Release"},{"key":"10.1016\/j.ejso.2025.110487_bib35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.molimm.2021.10.011","article-title":"Exosome-mediated transfer of lncRNA HCG18 promotes M2 macrophage polarization in gastric cancer","volume":"140","author":"Xin","year":"2021","journal-title":"Mol Immunol"},{"issue":"11","key":"10.1016\/j.ejso.2025.110487_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.70196","article-title":"A state\u2010of\u2010the\u2010art review on the recent advances in exosomes in oncogenic virus","volume":"7","author":"Ebrahimi","year":"2024","journal-title":"Health Sci Rep"},{"issue":"1","key":"10.1016\/j.ejso.2025.110487_bib37","article-title":"Multiple roles of exosomal long noncoding RNAs in cancers","volume":"2019","author":"Zhao","year":"2019","journal-title":"BioMed Res Int"},{"issue":"8","key":"10.1016\/j.ejso.2025.110487_bib38","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1080\/01616412.2024.2345024","article-title":"Lipid nanoparticle-encapsulated lncRNA DLX6-AS1 knockdown ameliorates cerebral ischemic injury via the Nrf2\/HO-1\/NLRP3 axis","volume":"46","author":"Song","year":"2024","journal-title":"Neurol Res"},{"key":"10.1016\/j.ejso.2025.110487_bib39","first-page":"2023","article-title":"Targeting lipid nanoparticles to the blood brain barrier to ameliorate acute ischemic stroke","author":"Nong","year":"2023","journal-title":"bioRxiv"},{"issue":"5\u20136","key":"10.1016\/j.ejso.2025.110487_bib41","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/10623320802487759","article-title":"Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro","volume":"15","author":"Candela","year":"2008","journal-title":"Endothelium"},{"key":"10.1016\/j.ejso.2025.110487_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/bs.apha.2014.06.001","article-title":"Transcytosis of macromolecules at the blood\u2013brain barrier","volume":"71","author":"Preston","year":"2014","journal-title":"Adv Pharmacol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110487_bib43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0006-8993(98)01282-7","article-title":"An improved low-permeability in vitro-model of the blood\u2013brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol","volume":"818","author":"Franke","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.ejso.2025.110487_bib44","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.coche.2020.08.009","article-title":"Caveolae-mediated transport at the injured blood\u2013brain barrier as an underexplored pathway for central nervous system drug delivery","volume":"30","author":"Sorets","year":"2020","journal-title":"Curr Opin Chem Eng"},{"issue":"9","key":"10.1016\/j.ejso.2025.110487_bib45","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-021-03098-6","article-title":"Interactions of lipids, lipoproteins, and apolipoproteins with the blood-brain barrier","volume":"38","author":"Rhea","year":"2021","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.ejso.2025.110487_bib46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tem.2013.10.003","article-title":"What are lipoproteins doing in the brain?","volume":"25","author":"Wang","year":"2014","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.ejso.2025.110487_bib47","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2147\/NDT.S206624","article-title":"The role of long noncoding RNA in traumatic brain injury","author":"Li","year":"2019","journal-title":"Neuropsychiatric Dis Treat"},{"issue":"13","key":"10.1016\/j.ejso.2025.110487_bib48","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1089\/neu.2016.4642","article-title":"Alteration in long non-coding RNA expression after traumatic brain injury in rats","volume":"34","author":"Wang","year":"2017","journal-title":"J Neurotrauma"},{"issue":"8","key":"10.1016\/j.ejso.2025.110487_bib49","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.tig.2013.03.002","article-title":"Long noncoding RNAs in development and disease of the central nervous system","volume":"29","author":"Ng","year":"2013","journal-title":"Trends Genet"},{"issue":"8","key":"10.1016\/j.ejso.2025.110487_bib53","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2174\/0113895575253875230922055711","article-title":"Roles of lncRNA-MALAT1 in the progression and prognosis of gliomas","volume":"24","author":"Ji","year":"2024","journal-title":"Mini Rev Med Chem"},{"issue":"8","key":"10.1016\/j.ejso.2025.110487_bib54","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1111\/jcmm.14435","article-title":"Long non\u2010coding RNA LINC00526 represses glioma progression via forming a double negative feedback loop with AXL","volume":"23","author":"Yan","year":"2019","journal-title":"J Cell Mol Med"},{"issue":"3","key":"10.1016\/j.ejso.2025.110487_bib55","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1159\/000478917","article-title":"Long non-coding RNA MALAT1 decreases the sensitivity of resistant glioblastoma cell lines to temozolomide","volume":"42","author":"Li","year":"2017","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"10.1016\/j.ejso.2025.110487_bib56","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1158\/0008-5472.CAN-18-0367","article-title":"Super-enhancer\u2013associated long noncoding RNA HCCL5 is activated by ZEB1 and promotes the malignancy of hepatocellular carcinoma","volume":"79","author":"Peng","year":"2019","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.ejso.2025.110487_bib57","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1172\/JCI87324","article-title":"Tumor immune profiling predicts response to anti\u2013PD-1 therapy in human melanoma","volume":"126","author":"Daud","year":"2016","journal-title":"J Clin Investig"},{"issue":"21","key":"10.1016\/j.ejso.2025.110487_bib58","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and ipilimumab versus ipilimumab in untreated melanoma","volume":"372","author":"Postow","year":"2015","journal-title":"N Engl J Med"},{"issue":"6382","key":"10.1016\/j.ejso.2025.110487_bib59","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"issue":"10088","key":"10.1016\/j.ejso.2025.110487_bib60","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"},{"issue":"7528","key":"10.1016\/j.ejso.2025.110487_bib61","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature13904","article-title":"MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer","volume":"515","author":"Powles","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ejso.2025.110487_bib62","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12943-018-0915-9","article-title":"BRD4 and Cancer: going beyond transcriptional regulation","volume":"17","author":"Donati","year":"2018","journal-title":"Mol Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2025.110487_bib63","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Lov\u00e9n","year":"2013","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ejso.2025.110487_bib64","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","article-title":"Transcriptional addiction in cancer","volume":"168","author":"Bradner","year":"2017","journal-title":"Cell"},{"issue":"D1","key":"10.1016\/j.ejso.2025.110487_bib65","doi-asserted-by":"crossref","first-page":"D172","DOI":"10.1093\/nar\/gkv1243","article-title":"SEA: a super-enhancer archive","volume":"44","author":"Wei","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"10.1016\/j.ejso.2025.110487_bib66","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.cell.2018.10.042","article-title":"Transcription factors activate genes through the phase-separation capacity of their activation domains","volume":"175","author":"Boija","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ejso.2025.110487_bib67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40246-023-00480-w","article-title":"Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progression","volume":"17","author":"Yang","year":"2023","journal-title":"Hum Genom"},{"issue":"7","key":"10.1016\/j.ejso.2025.110487_bib68","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1523\/JNEUROSCI.3389-16.2017","article-title":"Long noncoding RNA Malat1 regulates cerebrovascular pathologies in ischemic stroke","volume":"37","author":"Zhang","year":"2017","journal-title":"J Neurosci"},{"issue":"9","key":"10.1016\/j.ejso.2025.110487_bib69","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1111\/jcmm.14480","article-title":"LncRNA SNHG6 functions as a ceRNA to regulate neuronal cell apoptosis by modulating miR\u2010181c\u20105p\/BIM signalling in ischaemic stroke","volume":"23","author":"Zhang","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ejso.2025.110487_bib77","article-title":"Evolving landscape of long non-coding RNAs in cerebrospinal fluid: a key role from diagnosis to therapy in brain tumors","volume":"9","author":"Xu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ejso.2025.110487_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1392688","article-title":"Hidden regulators: the emerging roles of lncRNAs in brain development and disease","volume":"18","author":"Alammari","year":"2024","journal-title":"Front Neurosci"},{"issue":"3","key":"10.1016\/j.ejso.2025.110487_bib79","doi-asserted-by":"crossref","first-page":"225","DOI":"10.20517\/jtgg.2024.12","article-title":"The potential therapeutic applications of long non-coding RNAs","volume":"8","author":"Tamblin-Hopper","year":"2024","journal-title":"J Trans Gene Genom"},{"issue":"10","key":"10.1016\/j.ejso.2025.110487_bib80","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/jpm12101605","article-title":"Radio-lncRNAs: biological function and potential use as biomarkers for personalized oncology","volume":"12","author":"Koz\u0142owska-Mas\u0142o\u0144","year":"2022","journal-title":"J Personalized Med"},{"issue":"6","key":"10.1016\/j.ejso.2025.110487_bib81","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1227\/neu.0000000000002449","article-title":"The role of long noncoding ribonucleic acids in glioblastoma: what the neurosurgeon should know","volume":"92","author":"Villa","year":"2023","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ejso.2025.110487_bib83","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s11095-007-9379-0","article-title":"Blood\u2013brain barrier transport of therapeutics via receptor-mediation","volume":"24","author":"Jones","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.ejso.2025.110487_bib84","article-title":"Pathways for small molecule delivery to the central nervous system across the blood-brain barrier","volume":"6","author":"Mikitsh","year":"2014","journal-title":"Perspect Med Chem"},{"issue":"8","key":"10.1016\/j.ejso.2025.110487_bib85","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00018-022-04432-w","article-title":"ATP-binding cassette (ABC) drug transporters in the developing blood\u2013brain barrier: role in fetal brain protection","volume":"79","author":"Eng","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ejso.2025.110487_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the blood\u2013brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"Van Tellingen","year":"2015","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.ejso.2025.110487_bib87","series-title":"Basic fundamentals of drug delivery","first-page":"539","article-title":"Design and fabrication of brain-targeted drug delivery","author":"Soni","year":"2019"},{"issue":"4","key":"10.1016\/j.ejso.2025.110487_bib88","first-page":"128","article-title":"Blood\u2013brain barrier","volume":"11","author":"Lawther","year":"2011","journal-title":"Cont Educ Anaesth Crit Care Pain"},{"issue":"46","key":"10.1016\/j.ejso.2025.110487_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201801362","article-title":"Overcoming the blood\u2013brain barrier: the role of nanomaterials in treating neurological diseases","volume":"30","author":"Furtado","year":"2018","journal-title":"Adv Mater"},{"issue":"6","key":"10.1016\/j.ejso.2025.110487_bib90","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.7150\/thno.21254","article-title":"Current strategies for brain drug delivery","volume":"8","author":"Dong","year":"2018","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.ejso.2025.110487_bib91","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/ijmm.2012.1187","article-title":"New strategies for the treatment of lysosomal storage diseases","volume":"31","author":"Parenti","year":"2013","journal-title":"Int J Mol Med"},{"issue":"8","key":"10.1016\/j.ejso.2025.110487_bib92","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nbt.2247","article-title":"Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells","volume":"30","author":"Lippmann","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ejso.2025.110487_bib93","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"issue":"11","key":"10.1016\/j.ejso.2025.110487_bib94","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood\u2013brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"4","key":"10.1016\/j.ejso.2025.110487_bib95","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Nance","year":"2022","journal-title":"Nat Rev Mater"},{"issue":"21","key":"10.1016\/j.ejso.2025.110487_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111654","article-title":"Nanoparticles for targeted brain drug delivery: what do we know?","volume":"22","author":"Pinheiro","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.ejso.2025.110487_bib97","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.apsb.2021.05.020","article-title":"In vivo delivery of CRISPR-Cas9 therapeutics: progress and challenges","volume":"11","author":"Behr","year":"2021","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.ejso.2025.110487_bib98","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1021\/nn102357y","article-title":"Uniformity of drug payload and its effect on stability of solid lipid nanoparticles containing an ester prodrug","volume":"5","author":"Kim","year":"2011","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.ejso.2025.110487_bib99","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/s41563-021-01047-7","article-title":"Obstacles and opportunities in a forward vision for cancer nanomedicine","volume":"20","author":"de L\u00e1zaro","year":"2021","journal-title":"Nat Mater"},{"key":"10.1016\/j.ejso.2025.110487_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1194350","article-title":"The use of plant-derived exosome-like nanoparticles as a delivery system of CRISPR\/Cas9-based therapeutics for editing long non-coding RNAs in cancer colon cells","volume":"13","author":"Hillman","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2025.110487_bib101","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuint.2017.07.007","article-title":"Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases","volume":"112","author":"Kolli","year":"2018","journal-title":"Neurochem Int"},{"issue":"2","key":"10.1016\/j.ejso.2025.110487_bib102","article-title":"Ethical controversies and challenges in human genome editing","volume":"28","author":"Singh","year":"2021","journal-title":"Int Med J"},{"issue":"8","key":"10.1016\/j.ejso.2025.110487_bib103","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.4192","article-title":"Repair of double-strand breaks induced by CRISPR\u2013Cas9 leads to large deletions and complex rearrangements","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.ejso.2025.110487_bib104","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nmeth.4293","article-title":"Unexpected mutations after CRISPR\u2013Cas9 editing in vivo","volume":"14","author":"Schaefer","year":"2017","journal-title":"Nat Methods"},{"issue":"4","key":"10.1016\/j.ejso.2025.110487_bib105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2217\/pme-2018-0155","article-title":"The clinical application of gene editing: ethical and social issues","volume":"16","author":"Ormond","year":"2019","journal-title":"Pers Med"},{"issue":"16","key":"10.1016\/j.ejso.2025.110487_bib106","doi-asserted-by":"crossref","first-page":"dev150888","DOI":"10.1242\/dev.150888","article-title":"Gene editing in human development: ethical concerns and practical applications","volume":"145","author":"Rossant","year":"2018","journal-title":"Development"},{"issue":"9","key":"10.1016\/j.ejso.2025.110487_bib107","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3390\/pharmaceutics14091973","article-title":"Immune responses to gene editing by viral and non-viral delivery vectors used in retinal gene therapy","volume":"14","author":"Ren","year":"2022","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.ejso.2025.110487_bib108","first-page":"12","article-title":"Expression of long non-coding RNA CRNDE in glioma and its correlation with tumor progression and patient survival","volume":"20","author":"Jing","year":"2016","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ejso.2025.110487_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2012.06.004","article-title":"Long non-coding RNA expression profiles predict clinical phenotypes in glioma","volume":"48","author":"Zhang","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ejso.2025.110487_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-018-0822-0","article-title":"Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme","volume":"17","author":"Tan","year":"2018","journal-title":"Mol Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2025.110487_bib111","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41416-021-01672-8","article-title":"Non-coding RNAs as liquid biopsy biomarkers in cancer","volume":"126","author":"Toden","year":"2022","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2025.110487_bib112","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.molcel.2019.12.011","article-title":"Antisense-mediated transcript knockdown triggers premature transcription termination","volume":"77","author":"Lee","year":"2020","journal-title":"Mol Cell"},{"key":"10.1016\/j.ejso.2025.110487_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112051","article-title":"A concise review on the role of BDNF-AS in human disorders","volume":"142","author":"Ghafouri-Fard","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ejso.2025.110487_bib114","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jconrel.2021.01.027","article-title":"Minimally invasive nasal depot (MIND) technique for direct BDNF AntagoNAT delivery to the brain","volume":"331","author":"Padmakumar","year":"2021","journal-title":"J Contr Release"},{"issue":"11","key":"10.1016\/j.ejso.2025.110487_bib115","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat Protoc"},{"issue":"8","key":"10.1016\/j.ejso.2025.110487_bib116","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrd.2018.93","article-title":"Principles for targeting RNA with drug-like small molecules","volume":"17","author":"Warner","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.ejso.2025.110487_bib117","doi-asserted-by":"crossref","first-page":"E1509","DOI":"10.1073\/pnas.1616521114","article-title":"Gene activation of SMN by selective disruption of lncRNA-mediated recruitment of PRC2 for the treatment of spinal muscular atrophy","volume":"114","author":"Woo","year":"2017","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"10.1016\/j.ejso.2025.110487_bib118","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/ddr.21215","article-title":"Introduction to RNA\u2010Seq and its applications to drug discovery and development","volume":"75","author":"Khatoon","year":"2014","journal-title":"Drug Dev Res"},{"issue":"7","key":"10.1016\/j.ejso.2025.110487_bib119","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3390\/cancers13071555","article-title":"Noncoding RNAs in glioblastoma: emerging biological concepts and potential therapeutic implications","volume":"13","author":"Shahzad","year":"2021","journal-title":"Cancers"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325009151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325009151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T23:57:43Z","timestamp":1764028663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325009151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":114,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0748798325009151"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110487","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crossing the blood-brain barrier: The therapeutic potential of lncRNAs in neurosurgery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110487"}}